BioLineRx to Report Second Quarter 2026 Results on August 31, 2026
Go back to BioLineRx to Report Second Quarter 2026 Results on August 31, 2026| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.70 -0.15 (5.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.85 | 52 Week High | $1.63 | |||
| Open | $2.91 | 52 Week Low | $0.71 | |||
| Day High | $3.03 | P/E | N/A | |||
| Day Low | $2.65 | EPS | $0.00 | |||
| Volume | 13,044 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.70 -0.15 (5.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.85 | 52 Week High | $1.63 | |||
| Open | $2.91 | 52 Week Low | $0.71 | |||
| Day High | $3.03 | P/E | N/A | |||
| Day Low | $2.65 | EPS | $0.00 | |||
| Volume | 13,044 | |||||

